Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601.

[1]  C. Punt,et al.  Prognostic Value of Resection of Primary Tumor in Patients with Stage IV Colorectal Cancer: Retrospective Analysis of Two Randomized Studies and a Review of the Literature , 2012, Indian Journal of Surgical Oncology.

[2]  R. Berretta,et al.  A new case of primary signet-ring cell carcinoma of the cervix with prominent endometrial and myometrial involvement: Immunohistochemical and molecular studies and review of the literature , 2012, World Journal of Surgical Oncology.

[3]  I. Sobhani,et al.  Primary Colectomy in Patients With Stage IV Colon Cancer and Unresectable Distant Metastases Improves Overall Survival: Results of a Multicentric Study , 2011, Diseases of the colon and rectum.

[4]  J. Zell,et al.  Role of surgical resection among chemotherapy-treated patients with colorectal cancer stage IV disease: A survival analysis. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  T. Choueiri,et al.  The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy. , 2011, The Journal of urology.

[6]  N. Petrelli,et al.  A phase II trial of 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) chemotherapy plus bevacizumab (bev) for patients (pts) with unresectable stage IV colon cancer and a synchronous asymptomatic primary tumor: Results of NSABP C-10. , 2010 .

[7]  P. Morel,et al.  Neoadjuvant Chemotherapy in Patients with Stage IV Colorectal Cancer: A Comparison of Histological Response in Liver Metastases, Primary Tumors, and Regional Lymph Nodes , 2010, Annals of Surgical Oncology.

[8]  P. Buettner,et al.  Meta-Analysis of Survival of Patients with Stage IV Colorectal Cancer Managed with Surgical Resection Versus Chemotherapy Alone , 2010, World Journal of Surgery.

[9]  Wanling Xie,et al.  Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  D. Haller,et al.  Resection of the primary colorectal cancer is not necessary in nonobstructed patients with metastatic disease. , 2009, The oncologist.

[11]  J. Berlin,et al.  Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study. , 2009, The oncologist.

[12]  N. Kemeny,et al.  Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  T. de Baère,et al.  Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma. , 2009, Endocrine-related cancer.

[14]  Ahmedin Jemal,et al.  International Trends in Colorectal Cancer Incidence Rates , 2009, Cancer Epidemiology Biomarkers & Prevention.

[15]  S. Karandikar,et al.  Outcomes of resection and non-resection strategies in management of patients with advanced colorectal cancer , 2009, World journal of surgical oncology.

[16]  J. Bridgewater,et al.  Primary tumour resection and survival in the palliative management of metastatic colorectal cancer. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  N. Kemeny,et al.  Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  T. Ruers,et al.  Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  J. Tran van Nhieu,et al.  Chemotherapy Has Also an Effect on Primary Tumor in Colon Carcinoma , 2008, Annals of Surgical Oncology.

[20]  B. Mehrotra,et al.  Influence of palliative surgical resection on overall survival in patients with advanced colorectal cancer: a retrospective single institutional study , 2008, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[21]  M. Orditura,et al.  First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases. , 2008, Archives of surgery.

[22]  A. Neugut,et al.  Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review , 2008, International Journal of Colorectal Disease.

[23]  M. Koopman,et al.  A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  P. Loehrer.  Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial , 2008 .

[25]  J. Vauthey,et al.  Extending the frontiers of resectability in advanced colorectal cancer. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[26]  J. Pignon,et al.  Randomised Trial Comparing Three Different Schedules of Infusional 5FU and Raltitrexed Alone as First-Line Therapy in Metastatic Colorectal Cancer , 2006, Oncology.

[27]  N. Petrelli.  Expressing the Prochemotherapy Position on Treatment of Synchronous Colorectal Metastases in the Asymptomatic Patient , 2006, Annals of Surgical Oncology.

[28]  N. Petrelli.  Systemic chemotherapy should be the primary treatment of synchronous colorectal metastases in the asymptomatic patient [corrected]. , 2006, Annals of surgical oncology.

[29]  B. Nordlinger,et al.  Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases , 2005, The British journal of surgery.

[30]  R. Koch,et al.  Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: A multivariate analysis , 2005, Journal of surgical oncology.

[31]  L. Temple,et al.  Use of surgery among elderly patients with stage IV colorectal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  J. Guillem,et al.  Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. , 2003, Journal of the American College of Surgeons.

[33]  A. Norman,et al.  Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases , 2003, Gut.

[34]  W. Scheithauer,et al.  Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[35]  N. Munshi,et al.  Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. , 2001, The New England journal of medicine.

[36]  L. Assersohn,et al.  Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma , 1999, British Journal of Cancer.

[37]  S. Leach,et al.  Nonoperative Management of Primary Colorectal Cancer in Patients With Stage IV Disease , 1999, Annals of Surgical Oncology.

[38]  R. D. Hunter,et al.  WHO Handbook for Reporting Results of Cancer Treatment , 1980 .